Why Digital Pharma West Is the Number-One Provider of Content, Innovation and Practical Insights on the West Coast.
For 2018, we have spent a great deal of time conducting research and recruiting speakers from organizations of ALL sizes.
We've found that, regardless of their company size, life science marketers struggle with how to effectively, efficiently and compliantly deliver an optimal customer experience. However, certain challenges are universal. At
Digital Pharma West, we will explore these themes, delve into relevant questions and provide solutions to help overcome obstacles in your everyday business.
Deep Dive Content for 2018
- Digital/Commercial/Business transformation
- Patient solutions
- External collaboration with digital health companies, startups and non-traditional tech
- Real-world evidence data and analytics
- Healthbots and leveraging advanced engagement tools
- Blending marketing with sales: How to build into overall plans and how your sales can bring more tangible HCP feedback loops
- Operationalizing innovation - the how-to: War stories, navigating real world
- Omnichannel planning: KPIs, reporting metrics - how to bring them all together
2018 Overarching Themes to be Tackled
- How will digital disruption transform the pharma business model? Unlike other industries, the ''Uber'' of the pharma industry has yet to emerge, and the market remains ripe for digital disruption. Pharma companies are exploring how to transform through new business models to better engage their customers, streamline their operations, and stay competitive.
- How can pharma leverage digital and navigate digital trends and technologies to maximise positive outcomes for patients? Examining the adoption of digital across all industries is an important benchmarking process for pharma. Understanding how and why digital will impact healthcare and how patients can benefit is the key to developing successful and long-lasting engagement with your customer base. Therefore, identifying what a pharma company can do to address digital trends and emerging technologies is the first step in understanding what pharma companies will look like in the future and preparing for this transition of your business.
- How can pharma generate value from digital medicine solutions? As pharma companies shift from implementing traditional products to connected solutions, companies are challenged to define and realise value from this new business model (e.g., revenue stream) that intelligent digital medicine solutions require.
- How can pharma engage with disruptive technologies? AI, AR, and cognitive computing are now a reality and are being used by doctors and physicians in predictive diagnostics. If we start to advance toward diagnostics from AI on a regular basis and take certain decision-making processes out of the doctors' hands, what are the implications for pharma marketing? How will brands and marketing teams adapt to this new world?
- How can we demonstrate the value of digital for pharma products? Pharma companies are increasingly exploring the role that digital can play in demonstrating value through data, analytics, and real-world evidence.
Who Attends
This conference is designed for professionals from the pharmaceutical, biotechnology, biopharmaceutical and medical device industries whose responsibilities include:
- Marketing
- Digital Marketing
- Digital Strategy
- Integrated Marketing
- Multichannel Marketing
- Social Media
- Mobile Marketing
- eMarketing
- eBusiness
- Global Marketing
- Interactive Services
- Channels
- Innovation
- Customer Experience
- Customer Engagement Capabilities
- Field Force/ SFE
- Brand Management
- Product Management
- Strategic Operations
- PR/Communications
- New Media
- Advertising and Promotions
- IT
- Regulatory Affairs
- Regulatory Advertising
- Legal Counsel and MLR
- Compliance
Together with:
- Physician Networks
- ePatients
- Regulators
- Digital Agencies
- Technology Providers
Speakers
- Natassia Andari, Digital Marketing Manager, HEARTFLOW, INC
- Anna Haas Baumann, Director, Global Marketing, ALIGN TECHNOLOGY, INC
- Rebeca Bechily, Former Director, SHIRE
- Vanessa Braganza, Head of Global Multichannel Strategy and Operations, ABBVIE
- Jennifer Burnham, Content Strategy and Engagement, Digital Center of Excellence, ABBOTT
- David DeJonghe, Worldwide Director of Marketing - Digital Engagement and New Product Development, LIFESCAN, A JOHNSON & JOHNSON COMPANY
- Zoe Dunn, Principal, HALE ADVISORS
- Asha D’Souza, Executive Director, Global IST/IT Leader, INTARCIA THERAPEUTICS
- Lisa Flaiz, Director, Multichannel Marketing, Worldwide Digital Hub Lead, BRISTOL-MYERS SQUIBB
- Dan Gandor, Director, Digital Innovation and Corporate Program Management, TAKEDA PHARMACEUTICALS
- Justin Gardner, CEO, BLDG ACTIVE
- Ken Gordon, Director, Multimedia, SANOFI
- Tatsiana Gremyachinskiy, Digital Marketing U.S. Coronary Marketing, ABBOTT VASCULAR
- Shwen Gwee, Head of Digital Strategy, Global Clinical Operations, BIOGEN, USA
- Craig Hashi, Client Partner, Health, FACEBOOK
- Liz Hefner, Vice President of Marketing and Member Engagement, SKIPTA
- Kevin Hsieh, Director, Digital Marketing and Marketing Operations, AMAG PHARMACEUTICALS
- Jared Johnson, Manager, Marketing Technology and Analytics, PHOENIX CHILDREN’S HOSPITAL
- Omar Khateeb, Former Marketing Manager, Product and Platform Technologies, RESTORATION ROBOTICS
- Daniel Kraft, Physician-Scientist Faculty Chair of Medicine, SINGULARITY UNIVERSITY
- Alvin Lin, Director, U.S. Hematology Marketing,, PHARMACYCLICS
- Pat McWilliams, Head of Healthcare, Advertising, GOOGLE
- Andrew Moore, Associate Director Multichannel Solutions, Global Medical Affairs, ABBVIE
- Paul Murasko, Senior Director, Multichannel Marketing, SUNOVION PHARMACEUTICALS
- James Musick, Vice President, Head of Neurology Patient Technology U.S., UCB PHARMACEUTICALS
- Latika Nair, Director, Business Information Systems, ACTELION PHARMACEUTICALS
- Matt Nespoli, Digital Media Director, BUTLER/TILL HEALTH GROUP
- Mike Padilla, Vice President of Marketing, ALIMERA SCIENCES
- Amanda Phraner, Senior Manager, Public Relations and Social Media, HORIZON PHARMA
- Dalia Rayes, Senior Director, Business Unit Lead, ACTELION
- Alison Reichert, Director, Digital Strategy and Data Innovation, PFIZER, INC
- Dave Reim, Chief Product Officer, DMD
- Nicole Rojas, R&D Internal Communications, TAKEDA PHARMACEUTICALS
- Magdalena Schoeneich, Global Head of Digital Accelerator, R&D, TAKEDA PHARMACEUTICALS
- Jen Scroggins, Director, Lilly Brand, ELI LILLY
- Dr. Theodore Search, CEO, SKIPTA
- Altaf Shamji, Positioning and Branding Lead, OPDIVO and New Assets, Executive Sponsor, Marketing Excellence and Capabilities Lead, BRISTOL-MYERS SQUIBB
- Scarlett Shore Clifton, Product Manager and Platform Lead, VERILY
- Michael C. Song, Ph.D., Senior Manager R&D, Device Functionality, Safety, and Digital Connectivity, Drug Delivery and Device Development, BioPharmaceutical Development, MEDIMMUNE
- Karl Spilseth, Digital Marketing Manager, MEDTRONIC
- Eric Steckelman, Chief Growth Officer, GIANT
- Felipe Tilca, Senior Business System Analyst, ABBVIE
- John Vieira, Senior Director, In-Line Marketing, Psoriasis Patient Solutions, LEO PHARMA, USA
- Andrew Wint, Senior Vice President, Technology, GIANT
Please fill in your name and email to receive the conference agenda of this event.
Digital Pharma Innovation Lab and
Digital Future Day - June 11, 2018
Conference Day One - June 12, 2018
Conference Day Two - June 13, 2018
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Hyatt Regency San Francisco Airport1333 Bayshore Highway
Burlingame, CA 94010
To make reservations, please call 1-888-421-1442 or 402-592-6464 and request the negotiated rate for ExL’s 9th Digital Pharma West. To make reservations online:
Click HereThe group rate is available until May 21, 2018. Please book your room early, as rooms available at this rate are limited.
1-888-421-1442 or 402-592-6464
